MicroRNA-145 is involved in endothelial cell dysfunction and acts as a promising biomarker of acute coronary syndrome

go back to reference Makki N, Brennan TM, Girotra S. Acute coronary syndrome. J Intensive Care Med. 2015;30(4):186–200.PubMedCrossRef Makki N, Brennan TM, Girotra S. Acute coronary syndrome. J Intensive Care Med. 2015;30(4):186–200.PubMedCrossRef

go back to reference Dong CH, Wang ZM, Chen SY. Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: a systematic review and meta-analysis. Clin Biochem. 2018;52:131–6.PubMedCrossRef Dong CH, Wang ZM, Chen SY. Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: a systematic review and meta-analysis. Clin Biochem. 2018;52:131–6.PubMedCrossRef

go back to reference Bob-Manuel T, Ifedili I, Reed G, Ibebuogu UN, Khouzam RN. Non-ST elevation acute coronary syndromes: a comprehensive review. Curr Probl Cardiol. 2017;42(9):266–305.PubMedCrossRef Bob-Manuel T, Ifedili I, Reed G, Ibebuogu UN, Khouzam RN. Non-ST elevation acute coronary syndromes: a comprehensive review. Curr Probl Cardiol. 2017;42(9):266–305.PubMedCrossRef

go back to reference Gong L, Chang H, Zhang J, Guo G, Shi J, Xu H. Astragaloside IV protects rat cardiomyocytes from hypoxia-induced injury by down-regulation of miR-23a and miR-92a. Cell Physiol Biochem. 2018;49(6):2240–53.PubMedCrossRef Gong L, Chang H, Zhang J, Guo G, Shi J, Xu H. Astragaloside IV protects rat cardiomyocytes from hypoxia-induced injury by down-regulation of miR-23a and miR-92a. Cell Physiol Biochem. 2018;49(6):2240–53.PubMedCrossRef

go back to reference Crea F, Libby P. Acute coronary syndromes: the way forward from mechanisms to precision treatment. Circulation. 2017;136(12):1155–66.PubMedPubMedCentralCrossRef Crea F, Libby P. Acute coronary syndromes: the way forward from mechanisms to precision treatment. Circulation. 2017;136(12):1155–66.PubMedPubMedCentralCrossRef

go back to reference Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L, E American Heart Association Statistics Committee of the Council on, Prevention, C the Council on, and N Stroke. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014; 129(12):1350–69.PubMedCrossRef Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L, E American Heart Association Statistics Committee of the Council on, Prevention, C the Council on, and N Stroke. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014; 129(12):1350–69.PubMedCrossRef

go back to reference Jeong HS, Hong SJ, Cho SA, Kim JH, Cho JY, Lee SH, Joo HJ, Park JH, Yu CW, Lim DS. Comparison of ticagrelor versus prasugrel for inflammation, vascular function, and circulating endothelial progenitor cells in diabetic patients with non-ST-segment elevation acute coronary syndrome requiring coronary stenting: a prospective, randomized, crossover trial. JACC Cardiovasc Interv. 2017;10(16):1646–58.PubMedCrossRef Jeong HS, Hong SJ, Cho SA, Kim JH, Cho JY, Lee SH, Joo HJ, Park JH, Yu CW, Lim DS. Comparison of ticagrelor versus prasugrel for inflammation, vascular function, and circulating endothelial progenitor cells in diabetic patients with non-ST-segment elevation acute coronary syndrome requiring coronary stenting: a prospective, randomized, crossover trial. JACC Cardiovasc Interv. 2017;10(16):1646–58.PubMedCrossRef

go back to reference Lin Y, Cheng K, Wang T, Xie Q, Chen M, Chen Q, Wen Q. miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer. Biomed Pharmacother. 2017;95:1718–24.PubMedCrossRef Lin Y, Cheng K, Wang T, Xie Q, Chen M, Chen Q, Wen Q. miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer. Biomed Pharmacother. 2017;95:1718–24.PubMedCrossRef

go back to reference Zhong J, Ren X, Chen Z, Zhang H, Zhou L, Yuan J, Li P, Chen X, Liu W, Wu D, Yang X, Liu J. miR-21–5p promotes lung adenocarcinoma progression partially through targeting SET/TAF-Ialpha. Life Sci. 2019;231:116539.PubMedCrossRef Zhong J, Ren X, Chen Z, Zhang H, Zhou L, Yuan J, Li P, Chen X, Liu W, Wu D, Yang X, Liu J. miR-21–5p promotes lung adenocarcinoma progression partially through targeting SET/TAF-Ialpha. Life Sci. 2019;231:116539.PubMedCrossRef

go back to reference Negoita SI, Sandesc D, Rogobete AF, Dutu M, Bedreag OH, Papurica M, Ercisli MF, Popovici SE, Dumache R, Sandesc M, Dinu A, Sas AM, Serban D, Corneci D. miRNAs expressions and interaction with biological systems in patients with Alzheimer’s disease Using miRNAs as a diagnosis and prognosis biomarker. Clin Lab. 2017;63(9):1315–21.PubMed Negoita SI, Sandesc D, Rogobete AF, Dutu M, Bedreag OH, Papurica M, Ercisli MF, Popovici SE, Dumache R, Sandesc M, Dinu A, Sas AM, Serban D, Corneci D. miRNAs expressions and interaction with biological systems in patients with Alzheimer’s disease Using miRNAs as a diagnosis and prognosis biomarker. Clin Lab. 2017;63(9):1315–21.PubMed

go back to reference Tong KL, Mahmood Zuhdi AS, Wan Ahmad WA, Vanhoutte PM, de Magalhaes JP, Mustafa MR, Wong PF. Circulating MicroRNAs in young patients with acute coronary syndrome. Int J Mol Sci. 2018;19(5):1467.PubMedCentralCrossRef Tong KL, Mahmood Zuhdi AS, Wan Ahmad WA, Vanhoutte PM, de Magalhaes JP, Mustafa MR, Wong PF. Circulating MicroRNAs in young patients with acute coronary syndrome. Int J Mol Sci. 2018;19(5):1467.PubMedCentralCrossRef

go back to reference Bai R, Yang Q, Xi R, Li L, Shi D, Chen K. miR-941 as a promising biomarker for acute coronary syndrome. BMC Cardiovasc Disord. 2017;17(1):227.PubMedPubMedCentralCrossRef Bai R, Yang Q, Xi R, Li L, Shi D, Chen K. miR-941 as a promising biomarker for acute coronary syndrome. BMC Cardiovasc Disord. 2017;17(1):227.PubMedPubMedCentralCrossRef

go back to reference Ren J, Ma R, Zhang ZB, Li Y, Lei P, Men JL. Effects of microRNA-330 on vulnerable atherosclerotic plaques formation and vascular endothelial cell proliferation through the WNT signaling pathway in acute coronary syndrome. J Cell Biochem. 2018;119(6):4514–27.PubMedCrossRef Ren J, Ma R, Zhang ZB, Li Y, Lei P, Men JL. Effects of microRNA-330 on vulnerable atherosclerotic plaques formation and vascular endothelial cell proliferation through the WNT signaling pathway in acute coronary syndrome. J Cell Biochem. 2018;119(6):4514–27.PubMedCrossRef

go back to reference Zhang M, Cheng YJ, Sara JD, Liu LJ, Liu LP, Zhao X, Gao H. Circulating MicroRNA-145 is associated with acute myocardial infarction and heart failure. Chin Med J. 2017;130(1):51–6.PubMedPubMedCentralCrossRef Zhang M, Cheng YJ, Sara JD, Liu LJ, Liu LP, Zhao X, Gao H. Circulating MicroRNA-145 is associated with acute myocardial infarction and heart failure. Chin Med J. 2017;130(1):51–6.PubMedPubMedCentralCrossRef

go back to reference Su Q, Yao J, Sheng C. Geniposide attenuates LPS-induced injury via up-regulation of miR-145 in H9c2 cells. Inflammation. 2018;41(4):1229–377.PubMedCrossRef Su Q, Yao J, Sheng C. Geniposide attenuates LPS-induced injury via up-regulation of miR-145 in H9c2 cells. Inflammation. 2018;41(4):1229–377.PubMedCrossRef

go back to reference Hu S, Cao S, Tong Z, Liu J. FGF21 protects myocardial ischemia-reperfusion injury through reduction of miR-145-mediated autophagy. Am J Transl Res. 2018;10(11):3677–88.PubMedPubMedCentral Hu S, Cao S, Tong Z, Liu J. FGF21 protects myocardial ischemia-reperfusion injury through reduction of miR-145-mediated autophagy. Am J Transl Res. 2018;10(11):3677–88.PubMedPubMedCentral

go back to reference Xu H, Cao H, Zhu G, Liu S, Li H. Overexpression of microRNA-145 protects against rat myocardial infarction through targeting PDCD4. Am J Transl Res. 2017;9(11):5003–111.PubMedPubMedCentral Xu H, Cao H, Zhu G, Liu S, Li H. Overexpression of microRNA-145 protects against rat myocardial infarction through targeting PDCD4. Am J Transl Res. 2017;9(11):5003–111.PubMedPubMedCentral

go back to reference Nakaoka H, Hirono K, Yamamoto S, Takasaki I, Takahashi K, Kinoshita K, Takasaki A, Nishida N, Okabe M, Ce W, Miyao N, Saito K, Ibuki K, Ozawa S, Adachi Y, Ichida F. MicroRNA-145-5p and microRNA-320a encapsulated in endothelial microparticles contribute to the progression of vasculitis in acute Kawasaki disease. Sci Rep. 2018;8(1):1016.PubMedPubMedCentralCrossRef Nakaoka H, Hirono K, Yamamoto S, Takasaki I, Takahashi K, Kinoshita K, Takasaki A, Nishida N, Okabe M, Ce W, Miyao N, Saito K, Ibuki K, Ozawa S, Adachi Y, Ichida F. MicroRNA-145-5p and microRNA-320a encapsulated in endothelial microparticles contribute to the progression of vasculitis in acute Kawasaki disease. Sci Rep. 2018;8(1):1016.PubMedPubMedCentralCrossRef

go back to reference Ding Y, Zhang C, Zhang J, Zhang N, Li T, Fang J, Zhang Y, Zuo F, Tao Z, Tang S, Zhu W, Chen H, Sun X. miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-beta1 expression. Int J Oncol. 2017;50(5):1701–10.PubMedCrossRef Ding Y, Zhang C, Zhang J, Zhang N, Li T, Fang J, Zhang Y, Zuo F, Tao Z, Tang S, Zhu W, Chen H, Sun X. miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-beta1 expression. Int J Oncol. 2017;50(5):1701–10.PubMedCrossRef

go back to reference Li R, Shen Q, Wu N, He M, Liu N, Huang J, Lu B, Yao Q, Yang Y, Hu R. MiR-145 improves macrophage-mediated inflammation through targeting Arf6. Endocrine. 2018;60(1):73–82.PubMedCrossRef Li R, Shen Q, Wu N, He M, Liu N, Huang J, Lu B, Yao Q, Yang Y, Hu R. MiR-145 improves macrophage-mediated inflammation through targeting Arf6. Endocrine. 2018;60(1):73–82.PubMedCrossRef

go back to reference Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481–8.PubMedCrossRef Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481–8.PubMedCrossRef

go back to reference Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–e228.PubMedCrossRef Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–e228.PubMedCrossRef

go back to reference Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, Fonarow GC, Lange RA, Levine GN, Maddox TM, Naidu SS, Ohman EM, Smith PK. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;64(18):1929–49.PubMedCrossRef Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, Fonarow GC, Lange RA, Levine GN, Maddox TM, Naidu SS, Ohman EM, Smith PK. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;64(18):1929–49.PubMedCrossRef

go back to reference O'Gara PT, Kushner FG, Ascheim DD, Casey Jr DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW, G American College of Cardiology Foundation/American Heart Association Task Force on Practice. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 127(4):e362–425. O'Gara PT, Kushner FG, Ascheim DD, Casey Jr DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW, G American College of Cardiology Foundation/American Heart Association Task Force on Practice. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 127(4):e362–425.

go back to reference Liu H, Li G, Zhao W, Hu Y. Inhibition of MiR-92a may protect endothelial cells after acute myocardial infarction in rats: role of KLF2/4. Med Sci Monit. 2016;22:2451–62.PubMedPubMedCentralCrossRef Liu H, Li G, Zhao W, Hu Y. Inhibition of MiR-92a may protect endothelial cells after acute myocardial infarction in rats: role of KLF2/4. Med Sci Monit. 2016;22:2451–62.PubMedPubMedCentralCrossRef

go back to reference Wojciechowska A, Braniewska A, Kozar-Kaminska K. MicroRNA in cardiovascular biology and disease. Adv Clin Exp Med. 2017;26(5):865–74.PubMedCrossRef Wojciechowska A, Braniewska A, Kozar-Kaminska K. MicroRNA in cardiovascular biology and disease. Adv Clin Exp Med. 2017;26(5):865–74.PubMedCrossRef

go back to reference He X, Ji J, Wang T, Wang MB, Chen XL. Upregulation of circulating miR-195-3p in heart failure. Cardiology. 2017;138(2):107–14.PubMedCrossRef He X, Ji J, Wang T, Wang MB, Chen XL. Upregulation of circulating miR-195-3p in heart failure. Cardiology. 2017;138(2):107–14.PubMedCrossRef

go back to reference Wang EW, Jia XS, Ruan CW, Ge ZR. miR-487b mitigates chronic heart failure through inhibition of the IL-33/ST2 signaling pathway. Oncotarget. 2017;8(31):51688–702.PubMedPubMedCentral Wang EW, Jia XS, Ruan CW, Ge ZR. miR-487b mitigates chronic heart failure through inhibition of the IL-33/ST2 signaling pathway. Oncotarget. 2017;8(31):51688–702.PubMedPubMedCentral

go back to reference Li M, Liu Q, Lei J, Wang X, Chen X, Ding Y. MiR-362-3p inhibits the proliferation and migration of vascular smooth muscle cells in atherosclerosis by targeting ADAMTS1. Biochem Biophys Res Commun. 2017;493(1):270–6.PubMedCrossRef Li M, Liu Q, Lei J, Wang X, Chen X, Ding Y. MiR-362-3p inhibits the proliferation and migration of vascular smooth muscle cells in atherosclerosis by targeting ADAMTS1. Biochem Biophys Res Commun. 2017;493(1):270–6.PubMedCrossRef

go back to reference Li W, Li Z, Chen Y, Li S, Lv Y, Zhou W, Liao M, Zhu F, Zhou Z, Cheng X, Zeng Q, Liao Y, Wei Y. Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome upregulate proinflammatory cytokines expression in endothelial cells involving NF-kappaB pathway. J Immunol Res. 2014; 2014(342693. Li W, Li Z, Chen Y, Li S, Lv Y, Zhou W, Liao M, Zhu F, Zhou Z, Cheng X, Zeng Q, Liao Y, Wei Y. Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome upregulate proinflammatory cytokines expression in endothelial cells involving NF-kappaB pathway. J Immunol Res. 2014; 2014(342693.

go back to reference Luo XY, Zhu XQ, Li Y, Wang XB, Yin W, Ge YS, Ji WM. MicroRNA-150 restores endothelial cell function and attenuates vascular remodeling by targeting PTX3 through the NF-kappaB signaling pathway in mice with acute coronary syndrome. Cell Biol Int. 2018;42(9):1170–81.PubMedCrossRef Luo XY, Zhu XQ, Li Y, Wang XB, Yin W, Ge YS, Ji WM. MicroRNA-150 restores endothelial cell function and attenuates vascular remodeling by targeting PTX3 through the NF-kappaB signaling pathway in mice with acute coronary syndrome. Cell Biol Int. 2018;42(9):1170–81.PubMedCrossRef

go back to reference Darabi F, Aghaei M, Movahedian A, Elahifar A, Pourmoghadas A, Sarrafzadegan N. Association of serum microRNA-21 levels with Visfatin, inflammation, and acute coronary syndromes. Heart Vessels. 2017;32(5):549–57.PubMedCrossRef Darabi F, Aghaei M, Movahedian A, Elahifar A, Pourmoghadas A, Sarrafzadegan N. Association of serum microRNA-21 levels with Visfatin, inflammation, and acute coronary syndromes. Heart Vessels. 2017;32(5):549–57.PubMedCrossRef

go back to reference Lei C, Du F, Sun L, Li T, Li T, Min Y, Nie A, Wang X, Geng L, Lu Y, Zhao X, Shi Y, Fan D. miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6. Cell Death Dis. 2017;8(10):e3101.PubMedPubMedCentralCrossRef Lei C, Du F, Sun L, Li T, Li T, Min Y, Nie A, Wang X, Geng L, Lu Y, Zhao X, Shi Y, Fan D. miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6. Cell Death Dis. 2017;8(10):e3101.PubMedPubMedCentralCrossRef

go back to reference Cui C, Ye X, Chopp M, Venkat P, Zacharek A, Yan T, Ning R, Yu P, Cui G, Chen J. miR-145 regulates diabetes-bone marrow stromal cell-induced neurorestorative effects in diabetes stroke rats. Stem Cells Transl Med. 2016;5(12):1656–67.PubMedPubMedCentralCrossRef Cui C, Ye X, Chopp M, Venkat P, Zacharek A, Yan T, Ning R, Yu P, Cui G, Chen J. miR-145 regulates diabetes-bone marrow stromal cell-induced neurorestorative effects in diabetes stroke rats. Stem Cells Transl Med. 2016;5(12):1656–67.PubMedPubMedCentralCrossRef

go back to reference Sun N, Meng F, Xue N, Pang G, Wang Q, Ma H. Inducible miR-145 expression by HIF-1a protects cardiomyocytes against apoptosis via regulating SGK1 in simulated myocardial infarction hypoxic microenvironment. Cardiol J. 2018;25(2):268–78.PubMed Sun N, Meng F, Xue N, Pang G, Wang Q, Ma H. Inducible miR-145 expression by HIF-1a protects cardiomyocytes against apoptosis via regulating SGK1 in simulated myocardial infarction hypoxic microenvironment. Cardiol J. 2018;25(2):268–78.PubMed

go back to reference Zhang Y, Wen X, Hu XL, Cheng LZ, Yu JY, Wei ZB. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer. Eur Rev Med Pharmacol Sci. 2016;20(14):3026–30.PubMed Zhang Y, Wen X, Hu XL, Cheng LZ, Yu JY, Wei ZB. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer. Eur Rev Med Pharmacol Sci. 2016;20(14):3026–30.PubMed

go back to reference Wei H, Wen-Ming C, Jun-Bo J. Plasma miR-145 as a novel biomarker for the diagnosis and radiosensitivity prediction of human cervical cancer. J Int Med Res. 2017;45(3):1054–60.PubMedPubMedCentralCrossRef Wei H, Wen-Ming C, Jun-Bo J. Plasma miR-145 as a novel biomarker for the diagnosis and radiosensitivity prediction of human cervical cancer. J Int Med Res. 2017;45(3):1054–60.PubMedPubMedCentralCrossRef

go back to reference Yang F, Liu W, Yan X, Zhou H, Zhang H, Liu J, Yu M, Zhu X, Ma K. Effects of mir-21 on cardiac microvascular endothelial cells after acute myocardial infarction in rats: role of phosphatase and tensin homolog (PTEN)/vascular endothelial growth factor (VEGF) signal pathway. Med Sci Monit. 2016;22:3562–75.PubMedPubMedCentralCrossRef Yang F, Liu W, Yan X, Zhou H, Zhang H, Liu J, Yu M, Zhu X, Ma K. Effects of mir-21 on cardiac microvascular endothelial cells after acute myocardial infarction in rats: role of phosphatase and tensin homolog (PTEN)/vascular endothelial growth factor (VEGF) signal pathway. Med Sci Monit. 2016;22:3562–75.PubMedPubMedCentralCrossRef

go back to reference Huang J, Yang Q, He L, Huang J. Role of TLR4 and miR-155 in peripheral blood mononuclear cell-mediated inflammatory reaction in coronary slow flow and coronary arteriosclerosis patients. J Clin Lab Anal. 2018;32(2):e22232.CrossRef Huang J, Yang Q, He L, Huang J. Role of TLR4 and miR-155 in peripheral blood mononuclear cell-mediated inflammatory reaction in coronary slow flow and coronary arteriosclerosis patients. J Clin Lab Anal. 2018;32(2):e22232.CrossRef

go back to reference Shi J, Jiang K, Li Z. MiR-145 ameliorates neuropathic pain via inhibiting inflammatory responses and mTOR signaling pathway by targeting Akt3 in a rat model. Neurosci Res. 2018;134:10–7.PubMedCrossRef Shi J, Jiang K, Li Z. MiR-145 ameliorates neuropathic pain via inhibiting inflammatory responses and mTOR signaling pathway by targeting Akt3 in a rat model. Neurosci Res. 2018;134:10–7.PubMedCrossRef

go back to reference Jiang G, Huang C, Li J, Huang H, Jin H, Zhu J, Wu XR, Huang C. Role of STAT3 and FOXO1 in the divergent therapeutic responses of non-metastatic and metastatic bladder cancer cells to miR-145. Mol Cancer Ther. 2017;16(5):924–35.PubMedPubMedCentralCrossRef Jiang G, Huang C, Li J, Huang H, Jin H, Zhu J, Wu XR, Huang C. Role of STAT3 and FOXO1 in the divergent therapeutic responses of non-metastatic and metastatic bladder cancer cells to miR-145. Mol Cancer Ther. 2017;16(5):924–35.PubMedPubMedCentralCrossRef

go back to reference Hao W, Liu H, Zhou L, Sun Y, Su H, Ni J, He T, Shi P, Wang X. MiR-145 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells through targeting FoxO1. Exp Biol Med. 2018;243(4):386–93.CrossRef Hao W, Liu H, Zhou L, Sun Y, Su H, Ni J, He T, Shi P, Wang X. MiR-145 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells through targeting FoxO1. Exp Biol Med. 2018;243(4):386–93.CrossRef

go back to reference Gao Z, Liu R, Ye N, Liu C, Li X, Guo X, Zhang Z, Li X, Yao Y, Jiang X. FOXO1 inhibits tumor cell migration via regulating cell surface morphology in non-small cell lung cancer cells. Cell Physiol Biochem. 2018;48(1):138–48.PubMedCrossRef Gao Z, Liu R, Ye N, Liu C, Li X, Guo X, Zhang Z, Li X, Yao Y, Jiang X. FOXO1 inhibits tumor cell migration via regulating cell surface morphology in non-small cell lung cancer cells. Cell Physiol Biochem. 2018;48(1):138–48.PubMedCrossRef

go back to reference Li Z, He Q, Zhai X, You Y, Li L, Hou Y, He F, Zhao Y, Zhao J. Foxo1-mediated inflammatory response after cerebral hemorrhage in rats. Neurosci Lett. 2016;629:131–6.PubMedCrossRef Li Z, He Q, Zhai X, You Y, Li L, Hou Y, He F, Zhao Y, Zhao J. Foxo1-mediated inflammatory response after cerebral hemorrhage in rats. Neurosci Lett. 2016;629:131–6.PubMedCrossRef

go back to reference Zhang W, Chu S, Ding W, Wang F. Serum level of fibroblast growth factor 21 is independently associated with acute myocardial infarction. PLoS ONE. 2015;10(6):e0129791.PubMedPubMedCentralCrossRef Zhang W, Chu S, Ding W, Wang F. Serum level of fibroblast growth factor 21 is independently associated with acute myocardial infarction. PLoS ONE. 2015;10(6):e0129791.PubMedPubMedCentralCrossRef

go back to reference Chen H, Lu N, Zheng M. A high circulating FGF21 level as a prognostic marker in patients with acute myocardial infarction. Am J Transl Res. 2018;10(9):2958–66.PubMedPubMedCentral Chen H, Lu N, Zheng M. A high circulating FGF21 level as a prognostic marker in patients with acute myocardial infarction. Am J Transl Res. 2018;10(9):2958–66.PubMedPubMedCentral

go back to reference Sunaga H, Koitabashi N, Iso T, Matsui H, Obokata M, Kawakami R, Murakami M, Yokoyama T, Kurabayashi M. Activation of cardiac AMPK-FGF21 feed-forward loop in acute myocardial infarction: role of adrenergic overdrive and lipolysis byproducts. Sci Rep. 2019;9(1):11841.PubMedPubMedCentralCrossRef Sunaga H, Koitabashi N, Iso T, Matsui H, Obokata M, Kawakami R, Murakami M, Yokoyama T, Kurabayashi M. Activation of cardiac AMPK-FGF21 feed-forward loop in acute myocardial infarction: role of adrenergic overdrive and lipolysis byproducts. Sci Rep. 2019;9(1):11841.PubMedPubMedCentralCrossRef